Comments
Loading...

Bellerophon Therapeutics

BLPHOTCEM
Logo brought to you by Benzinga Data
$0.035000
00.00%
At Close: -
15 minutes delayed

Bellerophon Therapeutics (OTC:BLPH) Stock, Earnings Estimates, EPS, And Revenue

Bellerophon Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 14
EPS
$-0.160
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
$5.6M

Analyze the earnings history of Bellerophon Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Bellerophon Therapeutics (BLPH) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20232023-11-14$-0.16$-0.4463.6 %
Jun 20232023-08-14$-0.42$-0.40-5.00 %
Mar 20232023-05-15$0.27$-0.49155.1 %
Dec 20222023-03-31$-0.53$-0.48-10.4 %

Bellerophon Therapeutics (BLPH) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Bellerophon Therapeutics (OTCEM:BLPH) reporting earnings?

A

Bellerophon Therapeutics (BLPH) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on November 14, 2023 for Q3.

Q

What were the latest earnings per share (EPS) for Bellerophon Therapeutics (OTCEM:BLPH)?

A

The Actual EPS was $-0.16, which beat the estimate of $-0.44.

Q

What were Bellerophon Therapeutics’s (OTCEM:BLPH) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.